Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:GUD CVE:SUGR NYSEARCA:THCX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUDKnight TherapeuticsC$9.48+1.1%C$8.04C$5.66▼C$9.59C$930.74M-0.14178496,936 shs81,203 shsSUGRSugarBud Craft GrowersC$10.00C$12.08C$10.00▼C$13.90C$240.69M2.768948491 shs900 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/A10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUDKnight Therapeutics+0.54%+10.87%+8.82%+53.77%+56.33%SUGRSugarBud Craft Growers0.00%-18.37%-18.50%-0.10%-21.57%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUDKnight TherapeuticsC$9.48+1.1%C$8.04C$5.66▼C$9.59C$930.74M-0.14178496,936 shs81,203 shsSUGRSugarBud Craft GrowersC$10.00C$12.08C$10.00▼C$13.90C$240.69M2.768948491 shs900 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/A10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUDKnight Therapeutics+0.54%+10.87%+8.82%+53.77%+56.33%SUGRSugarBud Craft Growers0.00%-18.37%-18.50%-0.10%-21.57%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGUDKnight Therapeutics 3.00BuyC$9.501.06% UpsideSUGRSugarBud Craft Growers 0.00N/AN/AN/ATHCXAXS Cannabis ETF 1.99Reduce$16.60N/ACurrent Analyst Ratings BreakdownLatest SUGR, THCX, and GUD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2026GUDKnight Therapeutics Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuyC$9.50(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGUDKnight TherapeuticsC$510.45M1.81C$2.44 per share3.85C$8.00 per share1.18SUGRSugarBud Craft GrowersC$662.89M0.36C$0.09 per share110.00C$23.88 per share0.42THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGUDKnight Therapeutics-C$30.73MC$0.06156.67N/A1.10%0.73%0.51%N/ASUGRSugarBud Craft GrowersC$12.12MC$1.407.15N/AN/A2.11%10.07%5.13%N/ATHCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest SUGR, THCX, and GUD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026GUDKnight TherapeuticsN/AC$0.13N/AC$0.13N/AC$147.59 million3/19/2026Q4 2025GUDKnight TherapeuticsN/AC$0.09N/AC$0.09N/AC$133.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthGUDKnight TherapeuticsN/AN/AN/AN/AN/ASUGRSugarBud Craft GrowersN/A1.12%N/AN/AN/ATHCXAXS Cannabis ETF$0.724.34%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGUDKnight Therapeutics8.862.321.79SUGRSugarBud Craft Growers157.271.480.03THCXAXS Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGUDKnight Therapeutics23.93%SUGRSugarBud Craft Growers0.35%THCXAXS Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipGUDKnight Therapeutics45.62%SUGRSugarBud Craft Growers30.19%THCXAXS Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGUDKnight Therapeutics72598.18 millionN/ANot OptionableSUGRSugarBud Craft Growers4424.07 millionN/ANot OptionableTHCXAXS Cannabis ETFN/A8.50 millionN/ANot OptionableSUGR, THCX, and GUD HeadlinesRecent News About These CompaniesAurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - BuyJune 12 at 5:04 AM | seekingalpha.comHerbal Dispatch Completes 452kg Multi Client Medical Cannabis Export Shipment To EuropeJune 9 at 4:00 AM | newsfilecorp.comNHerbal Dispatch Completes Export of 261kg of Medical Cannabis to EuropeMay 21, 2026 | newsfilecorp.comNHerbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to EuropeMay 19, 2026 | newsfilecorp.comNAurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis ScienceMay 14, 2026 | prnewswire.comVillage Farms: U.S. Cannabis Optionality (Rating Upgrade)May 13, 2026 | seekingalpha.comGreen Thumb Industries Will Benefit From Medical Cannabis ReschedulingMay 12, 2026 | seekingalpha.comInnovative Industrial Properties: Medical Cannabis Rescheduling Implies Bottoming Tenant Default Risks - Reiterate BuyMay 6, 2026 | seekingalpha.comHerbal Dispatch Launches Next-Generation E-Commerce Platform, Targeting High-Growth $245 Million Insured Medical Cannabis SegmentMay 5, 2026 | newsfilecorp.comNGlow Lifetech Expands Distribution with Two of Canada's Largest Cannabis Retailers, Launches New Product Innovation and Advances National Growth StrategyApril 30, 2026 | newsfilecorp.comNCannabis ETFs: Regulatory Momentum Returns FocusApril 30, 2026 | etftrends.comEHerbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling ShiftApril 27, 2026 | newsfilecorp.comNAurora Cannabis: Why I Like This StockApril 24, 2026 | seekingalpha.comIM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash FlowMarch 31, 2026 | prnewswire.comCanopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis ClinicMarch 30, 2026 | businesswire.comHYTN Successfully Releases Cannabis Products in Germany and Accepts ReorderMarch 27, 2026 | globenewswire.comInnovative Industrial Properties: Deeply Undervalued As Cannabis Rescheduling Hits MilestoneMarch 27, 2026 | seekingalpha.comVillage Farms Shows Strong Q4 Performance But Cannabis Sector Remains Weak (Rating Downgrade)March 14, 2026 | seekingalpha.com3 Of The Best Cannabis Stocks In The Sector TodayMarch 9, 2026 | marijuanastocks.comMForget Tilray: This Cash‑Flow Monster Can Outlast Every Cannabis Hype CycleMarch 7, 2026 | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSUGR, THCX, and GUD Company DescriptionsKnight Therapeutics TSE:GUDC$9.48 +0.10 (+1.07%) As of 04:00 PM EasternKnight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.SugarBud Craft Growers CVE:SUGRC$10.00 0.00 (0.00%) As of 03:22 PM EasternSugarBud Craft Growers Corp. engages in the development, production, distribution, and sale of cannabis products in Canada. It offers cannabis extract, edible, and topical products through distributors and retailers, as well as to registered medical patients through CannMart.com. The company was formerly known as Relentless Resources Ltd. and changed its name to SugarBud Craft Growers Corp. in October 2018. SugarBud Craft Growers Corp. is headquartered in Calgary, Canada.AXS Cannabis ETF NYSEARCA:THCX$16.60 0.00 (0.00%) As of 03/1/2024The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Microsoft Just Gave Investors 3 Dates They Can't Afford to Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
